APO RESEARCH · REPORT
Epinephrine Auto-Injectors
Epinephrine auto-injector is an emergency injection ("shot") of epinephrine. It is used against life-threatening allergic reactions such as severe swelling, breathing problems, or loss of blood pressure. This medication is used in emergencies to treat very serious allergic reactions to insect stings/bites, foods, drugs, or other substances. Epinephrine acts quickly to improve breathing, stimulate the heart, raise a dropping blood pressure, reverse hives, and reduce swelling of the face, lips, and throat.
Product & engineering
Understand the product.
Epinephrine auto-injector is an emergency injection ("shot") of epinephrine. It is used against life-threatening allergic reactions such as severe swelling, breathing problems, or loss of blood pressure. This medication is used in emergencies to treat very serious allergic reactions to insect stings/bites, foods, drugs, or other substances. Epinephrine acts quickly to improve breathing, stimulate the heart, raise a dropping blood pressure, reverse hives, and reduce swelling of the face, lips, and throat.
Selected research
Industry Research
Epinephrine Auto-Injectors Industry Research Report 2026
Market perspective
Epinephrine auto-injector is an emergency injection ("shot") of epinephrine. It is used against life-threatening allergic reactions such as severe swelling, breathing problems, or loss of blood pressure. This medication is used in emergencies to treat very serious allergic reactions to insect stings/bites, foods, drugs, or other substances. Epinephrine acts quickly to improve breathing, stimulate the heart, raise a dropping blood pressure, reverse hives, and reduce swelling of the face, lips, and throat.
Global core Epinephrine Auto-Injectors manufacturers include Viatris, Teva Pharmaceutica etc. The top 1 company hold a share about 42%. North America is the largest market, with a share about 75%, followed by Europe which shares about 20%. In terms of product, 0.3 mg is the largest segment, with a share about 80%. And in terms of application, the largest end user is over 12 years patients.
Report Scope
Read the full market overview
This report quantifies the global Epinephrine Auto-Injectors market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Epinephrine Auto-Injectors Market by Company
Viatris
Teva Pharmaceutica
ALK Abello
Amneal Pharmaceuticals
Kaléo
Bioprojet Pharma
Bausch Health
Novartis Sandoz
Epinephrine Auto-Injectors Segment by Type
0.3 mg
0.15 mg
0.5 mg
0.1 mg
Epinephrine Auto-Injectors Segment by End User
Under 6 Years Patients
6 to 12 Years Patients
Over 12 Years Patients
Epinephrine Auto-Injectors Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epinephrine Auto-Injectors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Epinephrine Auto-Injectors and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epinephrine Auto-Injectors.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Epinephrine Auto-Injectors manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Epinephrine Auto-Injectors by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Epinephrine Auto-Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by end user, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.3 mg
- 0.15 mg
- 0.5 mg
- 0.1 mg
Applications
- Under 6 Years Patients
- 6 to 12 Years Patients
- Over 12 Years Patients
Companies covered
- Viatris
- Teva Pharmaceutica
- ALK Abello
- Amneal Pharmaceuticals
- Kaléo
- Bioprojet Pharma
- Bausch Health
- Novartis Sandoz
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Epinephrine Auto-Injectors Market Size (2021-2032)
- 2.2.2 Global Epinephrine Auto-Injectors Sales (2021-2032)
- 2.2.3 Global Epinephrine Auto-Injectors Market Average Price (2021-2032)
- 2.3 Epinephrine Auto-Injectors by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0.3 mg
- 2.3.3 0.15 mg
- 2.3.4 0.5 mg
- 2.3.5 0.1 mg
- 2.4 Epinephrine Auto-Injectors by End User
- 2.4.1 Market Value Comparison by End User (2021 VS 2025 VS 2032)
- 2.4.2 Under 6 Years Patients
- 2.4.3 6 to 12 Years Patients
- 2.4.4 Over 12 Years Patients
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Epinephrine Auto-Injectors Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Epinephrine Auto-Injectors Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Epinephrine Auto-Injectors Revenue of Manufacturers (2021-2026)
- 3.4 Global Epinephrine Auto-Injectors Average Price by Manufacturers (2021-2026)
- 3.5 Global Epinephrine Auto-Injectors Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Epinephrine Auto-Injectors, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Epinephrine Auto-Injectors, Product Type & Application
- 3.8 Global Manufacturers of Epinephrine Auto-Injectors, Established Date
- 3.9 Global Epinephrine Auto-Injectors Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Viatris
- 4.1.1 Viatris Company Information
- 4.1.2 Viatris Business Overview
- 4.1.3 Viatris Epinephrine Auto-Injectors Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Viatris Epinephrine Auto-Injectors Product Portfolio
- 4.1.5 Viatris Recent Developments
- 4.2 Teva Pharmaceutica
- 4.2.1 Teva Pharmaceutica Company Information
- 4.2.2 Teva Pharmaceutica Business Overview
- 4.2.3 Teva Pharmaceutica Epinephrine Auto-Injectors Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Teva Pharmaceutica Epinephrine Auto-Injectors Product Portfolio
- 4.2.5 Teva Pharmaceutica Recent Developments
- 4.3 ALK Abello
- 4.3.1 ALK Abello Company Information
- 4.3.2 ALK Abello Business Overview
- 4.3.3 ALK Abello Epinephrine Auto-Injectors Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 ALK Abello Epinephrine Auto-Injectors Product Portfolio
- 4.3.5 ALK Abello Recent Developments
- 4.4 Amneal Pharmaceuticals
- 4.4.1 Amneal Pharmaceuticals Company Information
- 4.4.2 Amneal Pharmaceuticals Business Overview
- 4.4.3 Amneal Pharmaceuticals Epinephrine Auto-Injectors Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Amneal Pharmaceuticals Epinephrine Auto-Injectors Product Portfolio
- 4.4.5 Amneal Pharmaceuticals Recent Developments
- 4.5 Kaléo
- 4.5.1 Kaléo Company Information
- 4.5.2 Kaléo Business Overview
- 4.5.3 Kaléo Epinephrine Auto-Injectors Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Kaléo Epinephrine Auto-Injectors Product Portfolio
- 4.5.5 Kaléo Recent Developments
- 4.6 Bioprojet Pharma
- 4.6.1 Bioprojet Pharma Company Information
- 4.6.2 Bioprojet Pharma Business Overview
- 4.6.3 Bioprojet Pharma Epinephrine Auto-Injectors Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Bioprojet Pharma Epinephrine Auto-Injectors Product Portfolio
- 4.6.5 Bioprojet Pharma Recent Developments
- 4.7 Bausch Health
- 4.7.1 Bausch Health Company Information
- 4.7.2 Bausch Health Business Overview
- 4.7.3 Bausch Health Epinephrine Auto-Injectors Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bausch Health Epinephrine Auto-Injectors Product Portfolio
- 4.7.5 Bausch Health Recent Developments
- 4.8 Novartis Sandoz
- 4.8.1 Novartis Sandoz Company Information
- 4.8.2 Novartis Sandoz Business Overview
- 4.8.3 Novartis Sandoz Epinephrine Auto-Injectors Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Novartis Sandoz Epinephrine Auto-Injectors Product Portfolio
- 4.8.5 Novartis Sandoz Recent Developments
5 Global Epinephrine Auto-Injectors Market Scenario by Region
- 5.1 Global Epinephrine Auto-Injectors Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Epinephrine Auto-Injectors Sales by Region: 2021-2032
- 5.2.1 Global Epinephrine Auto-Injectors Sales by Region: 2021-2026
- 5.2.2 Global Epinephrine Auto-Injectors Sales by Region: 2027-2032
- 5.3 Global Epinephrine Auto-Injectors Revenue by Region: 2021-2032
- 5.3.1 Global Epinephrine Auto-Injectors Revenue by Region: 2021-2026
- 5.3.2 Global Epinephrine Auto-Injectors Revenue by Region: 2027-2032
- 5.4 North America Epinephrine Auto-Injectors Market Facts & Figures by Country
- 5.4.1 North America Epinephrine Auto-Injectors Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Epinephrine Auto-Injectors Sales by Country (2021-2032)
- 5.4.3 North America Epinephrine Auto-Injectors Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Epinephrine Auto-Injectors Market Facts & Figures by Country
- 5.5.1 Europe Epinephrine Auto-Injectors Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Epinephrine Auto-Injectors Sales by Country (2021-2032)
- 5.5.3 Europe Epinephrine Auto-Injectors Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Epinephrine Auto-Injectors Market Facts & Figures by Country
- 5.6.1 Asia Pacific Epinephrine Auto-Injectors Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Epinephrine Auto-Injectors Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Epinephrine Auto-Injectors Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Epinephrine Auto-Injectors Market Facts & Figures by Country
- 5.7.1 South America Epinephrine Auto-Injectors Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Epinephrine Auto-Injectors Sales by Country (2021-2032)
- 5.7.3 South America Epinephrine Auto-Injectors Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Epinephrine Auto-Injectors Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Epinephrine Auto-Injectors Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Epinephrine Auto-Injectors Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Epinephrine Auto-Injectors Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Epinephrine Auto-Injectors Sales by Type (2021-2032)
- 6.1.1 Global Epinephrine Auto-Injectors Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Epinephrine Auto-Injectors Sales Market Share by Type (2021-2032)
- 6.2 Global Epinephrine Auto-Injectors Revenue by Type (2021-2032)
- 6.2.1 Global Epinephrine Auto-Injectors Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Epinephrine Auto-Injectors Revenue Market Share by Type (2021-2032)
- 6.3 Global Epinephrine Auto-Injectors Price by Type (2021-2032)
7 Segment by End User
- 7.1 Global Epinephrine Auto-Injectors Sales by End User (2021-2032)
- 7.1.1 Global Epinephrine Auto-Injectors Sales by End User (2021-2032) & (K Units)
- 7.1.2 Global Epinephrine Auto-Injectors Sales Market Share by End User (2021-2032)
- 7.2 Global Epinephrine Auto-Injectors Revenue by End User (2021-2032)
- 7.2.1 Global Epinephrine Auto-Injectors Sales by End User (2021-2032) & (US$ Million)
- 7.2.2 Global Epinephrine Auto-Injectors Revenue Market Share by End User (2021-2032)
- 7.3 Global Epinephrine Auto-Injectors Price by End User (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Epinephrine Auto-Injectors Value Chain Analysis
- 8.1.1 Epinephrine Auto-Injectors Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Epinephrine Auto-Injectors Production Mode & Process
- 8.2 Epinephrine Auto-Injectors Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Epinephrine Auto-Injectors Distributors
- 8.2.3 Epinephrine Auto-Injectors Customers
9 Global Epinephrine Auto-Injectors Analyzing Market Dynamics
- 9.1 Epinephrine Auto-Injectors Industry Trends
- 9.2 Epinephrine Auto-Injectors Industry Drivers
- 9.3 Epinephrine Auto-Injectors Industry Opportunities and Challenges
- 9.4 Epinephrine Auto-Injectors Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst